We’re proud to announce that our Business Case titled “Getting better, faster: The Case for Optimizing access to Precision Medicine in the Wake of the Revolution in Cancer Care” has officially launched. 

Co-written by Louise Binder and Ethan Pigott, this Paper is a comprehensive treatise on the history of the research of precision medicine, its successes to date and its promise for the future. It also describes the barriers to access that are presented by public and some private reimbursement plans. It includes a set of recommendations to enhance research and access to these important innovative treatments.

In October 2023, we hosted a 2 day webinar series based on the Business Case. Led by advocates, patient groups and medical experts, this webinar delved further into the Business Case and precision medicine as it relates to the Canadian medical landscape. Click here to watch the recordings.